Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Haematologica
|
July 16, 2016
Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients
Siobán B Keel, Angela Scott, Marilyn Sanchez-Bonilla, et al.
Blood
|
March 19, 2005
Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes
M Lee Lucas, Nancy E Seidel, Christopher D Porada, et al.
Cell
|
September 17, 2004
Identification of a human heme exporter that is essential for erythropoiesis
John G Quigley, Zhantao Yang, Mark T Worthington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2015
Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia
Xueyan Chen, Hu Xie, Brent L Wood, et al.
British Journal of Haematology
|
March 11, 2024
Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopag
Brynn B Duncan, Jennifer L Lotter, Jeanine Superata, et al.
Blood
|
April 24, 2019
Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes
Jasper Hsu, Andreea Reilly, Brian J Hayes, et al.
Science (New York, N.Y.)
|
February 9, 2008
A heme export protein is required for red blood cell differentiation and iron homeostasis
Siobán B Keel, Raymond T Doty, Zhantao Yang, et al.
The Journal of Nutrition
|
May 20, 2011
Placental expression of the heme transporter, feline leukemia virus subgroup C receptor, is related to maternal iron status in pregnant adolescents
Lindsay M Jaacks, Melissa F Young, Bridget V Essley, et al.
JAMA Oncology
|
May 9, 2024
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial
Noam E Kopmar, Kim Quach, Ted A Gooley, et al.
Blood
|
July 24, 2009
The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells
Vivian G Oehler, Katherine A Guthrie, Carrie L Cummings, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Haematologica
|
July 16, 2016
Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients
Siobán B Keel, Angela Scott, Marilyn Sanchez-Bonilla, et al.
Blood
|
March 19, 2005
Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes
M Lee Lucas, Nancy E Seidel, Christopher D Porada, et al.
Cell
|
September 17, 2004
Identification of a human heme exporter that is essential for erythropoiesis
John G Quigley, Zhantao Yang, Mark T Worthington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2015
Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia
Xueyan Chen, Hu Xie, Brent L Wood, et al.
British Journal of Haematology
|
March 11, 2024
Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopag
Brynn B Duncan, Jennifer L Lotter, Jeanine Superata, et al.
Blood
|
April 24, 2019
Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes
Jasper Hsu, Andreea Reilly, Brian J Hayes, et al.
Science (New York, N.Y.)
|
February 9, 2008
A heme export protein is required for red blood cell differentiation and iron homeostasis
Siobán B Keel, Raymond T Doty, Zhantao Yang, et al.
The Journal of Nutrition
|
May 20, 2011
Placental expression of the heme transporter, feline leukemia virus subgroup C receptor, is related to maternal iron status in pregnant adolescents
Lindsay M Jaacks, Melissa F Young, Bridget V Essley, et al.
JAMA Oncology
|
May 9, 2024
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial
Noam E Kopmar, Kim Quach, Ted A Gooley, et al.
Blood
|
July 24, 2009
The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells
Vivian G Oehler, Katherine A Guthrie, Carrie L Cummings, et al.
Page
of 8